Knight Theraps Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KNIGHT THERAPS, and what generic and branded alternatives to KNIGHT THERAPS drugs are available?
KNIGHT THERAPS has one approved drug.
Drugs and US Patents for Knight Theraps
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Knight Theraps | IMPAVIDO | miltefosine | CAPSULE;ORAL | 204684-001 | Mar 19, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.